These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16477542)

  • 1. Does autoantibody-negative Graves' disease exist? A second evaluation of the clinical diagnosis.
    Paunkovic J; Paunkovic N
    Horm Metab Res; 2006 Jan; 38(1):53-6. PubMed ID: 16477542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
    Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
    Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of M22-based ELISA and human-TSH-receptor-based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases.
    Liu C; Hermsen D; Domberg J; Graeber C; Hautzel H; Duan Y; Xu KF; Liu CP; Mao XD; Cupisti K; Scherbaum WA; Schott M
    Horm Metab Res; 2008 Jul; 40(7):479-83. PubMed ID: 18504673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial.
    Schott M; Hermsen D; Broecker-Preuss M; Casati M; Mas JC; Eckstein A; Gassner D; Golla R; Graeber C; van Helden J; Inomata K; Jarausch J; Kratzsch J; Miyazaki N; Moreno MA; Murakami T; Roth HJ; Stock W; Noh JY; Scherbaum WA; Mann K
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):566-73. PubMed ID: 19170704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
    Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
    Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are porcine and human TSH receptor antibody measurements comparable?
    Zöphel K; von Landenberg P; Roggenbuck D; Wunderlich G; Kotzerke J; Lackner KJ
    Clin Lab; 2008; 54(1-2):1-8. PubMed ID: 18510037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay.
    Meller J; Jauho A; Hüfner M; Gratz S; Becker W
    Thyroid; 2000 Dec; 10(12):1073-9. PubMed ID: 11201852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
    Quadbeck B; Hoermann R; Hahn S; Roggenbuck U; Mann K; Janssen OE
    Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease.
    Hovens GC; Buiting AM; Karperien M; Ballieux BE; van der Pluijm G; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease.
    Goh SY; Ho SC; Seah LL; Fong KS; Khoo DH
    Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinction between autoimmune and non-autoimmune hyperthyroidism by determination of TSH-receptor antibodies in patients with the initial diagnosis of toxic multinodular goiter.
    Wallaschofski H; Orda C; Georgi P; Miehle K; Paschke R
    Horm Metab Res; 2001 Aug; 33(8):504-7. PubMed ID: 11544566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of Thyroid-Stimulating Immunoglobulin Bioassay and Thyrotropin-Binding Inhibitory Immunoglobulin Assay for the Diagnosis of Graves' Disease in Patients With Active Thyrotoxicosis.
    Silva de Morais N; Angell TE; Ahmadi S; Alexander EK; Dos Santos Teixeira PF; Marqusee E
    Endocr Pract; 2022 May; 28(5):502-508. PubMed ID: 35091101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a solid phase human- versus porcine- thyrotropin receptor-based immunoassay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases.
    Hermsen D; Liu C; Domberg J; Graeber C; Feldkamp J; Duan Y; Xu K; Liu C; Mao X; Scherbaum WA; Schott M
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S59-63. PubMed ID: 18777457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays.
    Zöphel K; Roggenbuck D; von Landenberg P; Wunderlich G; Grüning T; Kotzerke J; Lackner KJ; Rees Smith B
    Horm Metab Res; 2010 Jan; 42(1):65-9. PubMed ID: 19830651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
    Giovanella L; Ceriani L; Garancini S
    Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On specificity of 2nd generation TSH receptor autoantibody measurements.
    Zöphel K; Grüning T; Roggenbuck D; Wunderlich G; Kotzerke J
    Clin Lab; 2008; 54(7-8):243-9. PubMed ID: 18942492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin receptor antibodies detected by the human recombinant TBII assay--a surrogate marker for autoimmune activity in Graves' ophthalmopathy?
    Myśliwiec J; Kretowski A; Stepień A; Mirończuk K; Kinalska I
    Med Sci Monit; 2002 Sep; 8(9):MT159-62. PubMed ID: 12218953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study.
    Vos XG; Smit N; Endert E; Tijssen JG; Wiersinga WM
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):311-7. PubMed ID: 18208575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.